Terms ending in 2030
Every in-force patent on Oncotherapy Science, Inc.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,090,680 | Antibodies That Specifically Bind to Abeta Oligomers and Uses Thereof In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 9,115,207 | A Method of Inducing an Immune Response by Administering Wdrpuh Epitope Peptides In force · High confidence | OncoTherapy Science, Inc. | In force | High confidence | |
| US 8,455,444 | CDH3 Peptide and Medicinal Agent Comprising the Same In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 8,617,562 | FOXM1 Peptides and Immunogenic Compositions Containing Them In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 9,446,106 | NEIL3 Peptides and Vaccines Including the Same In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 9,975,935 | NEIL3 Peptides and Vaccines Including the Same In force · High confidence | OncoTherapy Science, Inc. | In force | High confidence | |
| US 8,674,069 | Melk Epitope Peptides and Vaccines Containing the Same In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 9,387,238 | CDCA1 Epitope Peptides and Vaccines Containing the Same In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 8,333,967 | Anti-Aß Oligomer Humanized Antibody In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| US 9,181,332 | Anti-A(BETA) Oligomer Humanized Antibody In force · High confidence | Oncotherapy Science, Inc. | In force | High confidence | |
| 2 more term ends in 2030 · Pro | |||||
10 of 12 patents shown. Soonest term end first, then patent number.
Pro members see all 12.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.